Assessment cycle 2026 Q3 — page 15
Documents ratified in the 2026 Q3 assessment cycle, which ran from 1 July 2026 to 30 September 2026 and was ratified on 18 September 2026.
Documents ratified
-
Comment-period correspondent, regulatory science. Regulatory affairs, generic medicines sector
30 Jul 2026 -
Comment-period correspondent, health-technology assessment. Health-technology assessment agency
30 Jul 2026 -
Comment-period correspondent, health-technology assessment. Health-technology assessment agency
30 Jul 2026 -
Peptides, SARMs, injectable oils and raw materials.
29 Aug 2026 -
Research-catalogue peptides, SARMs, injectable oils and raw materials, supplied against the company’s own specification.
12 Jul 2026 -
Solid-phase synthesis of research peptides with a 350+ line catalogue spanning peptides, sarms, injectable oils, oral tablets and raw materials, released against four…
12 Sep 2026
page 15 of 15